Alaunos Therapeutics
(NASDAQ:TCRT)
$1.15
-0.03[-2.54%]
At close: Apr 23
$1.15
0[0.00%]
After Hours: 5:07PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Alaunos Therapeutics Stock (NASDAQ:TCRT), Quotes and News Summary

Alaunos Therapeutics Stock (NASDAQ: TCRT) stock price, news, charts, stock research, profile.

Open$1.150
Close$1.160
Volume / Avg.9.254K / 114.603K
Day Range1.071 - 1.195
52 Wk Range0.660 - 10.470
Market Cap$18.414M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
30
Short Interest
9.92%
Days to Cover23.98

Recent News

Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Avi Kapoor
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of WD-40 Company (NASDAQ: WDFC) rose sharply during Wednesday’s session after the company reported better-than-expected first-quarter results.
Avi Kapoor
Why Dermata Therapeutics Shares Are Trading Higher By Over 57%; Here Are 20 Stocks Moving Premarket
Shares of Dermata Therapeutics, Inc. (NASDAQ: DRMA) rose sharply in pre-market trading after the company announced the issuance of a new patent in Japan for its DMT410 program for the treatment of hyperhidrosis. Dermata Therapeutics shares jumped 57.3% to $0.9601 in pre-market trading.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Alaunos Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treat...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
TCRT
CERO

FAQ

Q

How do I buy Alaunos Therapeutics (TCRT) stock?

A

You can purchase shares of Alaunos Therapeutics (NASDAQ: TCRT) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Alaunos Therapeutics's (TCRT) competitors?

A

Other companies in Alaunos Therapeutics’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Vaxxinity (NASDAQ:VAXX) and Dominari Holdings (NASDAQ:DOMH).

Q

What is the target price for Alaunos Therapeutics (TCRT) stock?

A

The latest price target for Alaunos Therapeutics (NASDAQ: TCRT) was reported by HC Wainwright & Co. on Wednesday, August 16, 2023. The analyst firm set a price target for 0.00 expecting TCRT to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Alaunos Therapeutics (TCRT)?

A

The stock price for Alaunos Therapeutics (NASDAQ: TCRT) is $1.15 last updated April 23, 2024 at 5:07 PM EDT.

Q

Does Alaunos Therapeutics (TCRT) pay a dividend?

A

There are no upcoming dividends for Alaunos Therapeutics.

Q

When is Alaunos Therapeutics (NASDAQ:TCRT) reporting earnings?

A

Alaunos Therapeutics’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Q

Is Alaunos Therapeutics (TCRT) going to split?

A

There is no upcoming split for Alaunos Therapeutics.

Q

What sector and industry does Alaunos Therapeutics (TCRT) operate in?

A

Alaunos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch